Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q4 2017 · 10-K
Revenue$61.42M$61.42Mno prior Q4 2016 on file Net Income$4.55M$4.55MN/M vs Q4 2016 EPS Diluted$0.02$0.02N/M vs Q4 2016 Gross Profit$26,762,000−1.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$5,759,000N/M Free Cash Flowderived$2,236,000N/M Margins · derivedGross margin43.6%
Operating margin6.0%
Net margin7.4%
ended Dec 31, 2017 · filed Mar 13, 2018 · 72 d after period end